Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_assertion type Assertion NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_head.
- NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_assertion description "[The distribution of the NR2b genotypes (p = 0.600) and alleles (p = 0.652) did not differ significantly between AD patients and controls, however, suggesting that it is unlikely that the NR2b C2664T polymorphism plays a substantial role in conferring susceptibility to AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_provenance.
- NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_assertion evidence source_evidence_literature NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_provenance.
- NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_assertion SIO_000772 11844890 NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_provenance.
- NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_assertion wasDerivedFrom befree-20150227 NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_provenance.
- NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_assertion wasGeneratedBy ECO_0000203 NP434569.RARuwugbfZ9wv8dhySfPrlZOOXGGBVmlaw_Lf2E5LguQ0130_provenance.